Stockreport

Travere Awaits FDA FILSPARI Ruling As Valuation Gap Draws Attention [Yahoo! Finance]

Travere Therapeutics, Inc.  (TVTX) 
PDF Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Travere Therapeutics is awaiting an FDA decision on a label expansion for FIL [Read more]